Patent Ruling In India Could Boost Exports Of Cheap Medicine To Third World
Novartis lost its bid to patent one of its cancer drugs. Indian authorities say the drug is too much like an earlier version. Novartis says the ruling may dampen drug companies' willingness to work in India. Others say the ruling will help make less expensive drugs available to the world's poor.